BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31157203)

  • 1. Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples.
    Antonides LH; Cannaert A; Norman C; Vives L; Harrison A; Costello A; Nic Daeid N; Stove CP; Sutcliffe OB; McKenzie C
    Front Chem; 2019; 7():321. PubMed ID: 31157203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and
    Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
    ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons.
    Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C
    Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of carboxamide-type synthetic cannabinoids as CB
    Doi T; Tagami T; Takeda A; Asada A; Sawabe Y
    Forensic Toxicol; 2018; 36(1):51-60. PubMed ID: 29367862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
    Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market.
    Brandon AM; Antonides LH; Riley J; Epemolu O; McKeown DA; Read KD; McKenzie C
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33807614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
    Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
    ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
    Wilson CD; Hiranita T; Fantegrossi WE
    Drug Alcohol Depend; 2022 Jul; 236():109468. PubMed ID: 35643039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2-alkyl-2
    Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M
    Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Steric Requirements at CB
    Markham J; Sparkes E; Boyd R; Chen S; Manning JJ; Finlay D; Lai F; McGregor E; Maloney CJ; Gerona RR; Connor M; McGregor IS; Hibbs DE; Glass M; Kevin RC; Banister SD
    ACS Chem Neurosci; 2022 Apr; 13(8):1281-1295. PubMed ID: 35404067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
    Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
    Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioseparation of the carboxamide-type synthetic cannabinoids N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide and methyl [1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-valinate in illicit herbal products.
    Doi T; Asada A; Takeda A; Tagami T; Katagi M; Kamata H; Sawabe Y
    J Chromatogr A; 2016 Nov; 1473():83-89. PubMed ID: 27773389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
    Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
    Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L-valine or L-tert-leucine.
    Wouters E; Mogler L; Cannaert A; Auwärter V; Stove C
    Drug Test Anal; 2019 Aug; 11(8):1183-1191. PubMed ID: 31021521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11.
    Kevin RC; Cairns EA; Boyd R; Arnold JC; Bowen MT; McGregor IS; Banister SD
    Front Psychiatry; 2022; 13():1048836. PubMed ID: 36590635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.
    Cabanlong CV; Russell LN; Fantegrossi WE; Prather PL
    Toxicol Sci; 2022 Apr; 187(1):175-185. PubMed ID: 35201352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
    Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
    Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.